{"disease":{"id":"pneumonia-ventilator-associated","name":"pneumonia ventilator associated"},"drugs":{"marketed":[{"drug_id":"zavicefta-ceftazidime-avibactam","indication_name":"Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by certain susceptible bacteria.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zavicefta, Ceftazidime-Avibactam","generic_name":"zavicefta-ceftazidime-avibactam","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Bacterial cell wall synthesis","drug_class":"Cephalosporin antibiotic and beta-lactamase inhibitor combination","quality_score":55,"revenue":"638","mechanism":""},{"drug_id":"relebactam","indication_name":"Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05060718","title":"HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia Strategies","phase":"","overall_status":"COMPLETED","enrollment_count":2165,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT03105414","title":"INCIPAVE Study: Incidence of Ventilator Acquired Pneumonia in Children","phase":"","overall_status":"UNKNOWN","enrollment_count":2100,"lead_sponsor_name":"Sylvie Chevret","has_results":false},{"nct_id":"NCT03348579","title":"Hospital-acquired Pneumonia in Intensive Care Unit","phase":"","overall_status":"COMPLETED","enrollment_count":1850,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT05117125","title":"Biomarkers for Ventilator-associated Pneumonia","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT03149640","title":"Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":850,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT02070757","title":"Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":726,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT05204563","title":"Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Evopoint Biosciences Inc.","has_results":true},{"nct_id":"NCT03329092","title":"A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":422,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03506191","title":"Pneumonia Due to Stenotrophomonas Maltophilia in ICUs","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT03032380","title":"Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT07052604","title":"Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier de Saint-Denis","has_results":false},{"nct_id":"NCT03303937","title":"Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients","phase":"","overall_status":"COMPLETED","enrollment_count":289,"lead_sponsor_name":"Hôpital Louis Mourier","has_results":false},{"nct_id":"NCT03583333","title":"Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07326540","title":"Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":248,"lead_sponsor_name":"BioVersys SAS","has_results":false},{"nct_id":"NCT00986102","title":"PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT05624684","title":"Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Avicenna Military Hospital","has_results":false},{"nct_id":"NCT03894046","title":"Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Entasis Therapeutics","has_results":true},{"nct_id":"NCT04313946","title":"Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Professor Adrian Covic","has_results":false},{"nct_id":"NCT06467864","title":"Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03401463","title":"Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar","phase":"NA","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Jagiellonian University","has_results":false},{"nct_id":"NCT04755972","title":"Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Clinical Hospital Center, Split","has_results":false},{"nct_id":"NCT03816956","title":"Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Aridis Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06181669","title":"Pneumonia Direct Pilot","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03711331","title":"Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT02714595","title":"Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT05843786","title":"Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05905055","title":"P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Meiji Seika Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT05952648","title":"HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array","phase":"NA","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07181824","title":"VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Centre Hospitalier Sud Francilien","has_results":false},{"nct_id":"NCT07268560","title":"Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Sir Run Run Shaw Hospital","has_results":false},{"nct_id":"NCT06039995","title":"The Efficacy of Adjuvant Oral Care in Prevention of Ventilator Associated Pneumonia.","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Health Sciences Lahore","has_results":true},{"nct_id":"NCT04215991","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Shionogi","has_results":false},{"nct_id":"NCT02753608","title":"Early Detection of Ventilator-associated Pneumonia (VAP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT01970371","title":"A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Achaogen, Inc.","has_results":true},{"nct_id":"NCT04215692","title":"Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients","phase":"NA","overall_status":"SUSPENDED","enrollment_count":68,"lead_sponsor_name":"Instituto Mexicano del Seguro Social","has_results":false},{"nct_id":"NCT04882085","title":"Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04264533","title":"Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"ZhiYong Peng","has_results":false},{"nct_id":"NCT06848010","title":"TRacheal Cuff PRessure Evaluation Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":54,"lead_sponsor_name":"Policlinico Hospital","has_results":false},{"nct_id":"NCT05214716","title":"FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units","phase":"NA","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Kyungmin Huh","has_results":false},{"nct_id":"NCT05258682","title":"Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Mucpharm Pty Ltd","has_results":false},{"nct_id":"NCT03290105","title":"Microbial and Pharmacological Assessment of Chlorhexidine","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hôpital Louis Mourier","has_results":false},{"nct_id":"NCT04269525","title":"Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":16,"lead_sponsor_name":"ZhiYong Peng","has_results":false},{"nct_id":"NCT04346589","title":"Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients","phase":"NA","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"A.O. Ospedale Papa Giovanni XXIII","has_results":false},{"nct_id":"NCT04566172","title":"Preoperative Optimization to Improve Functional Status","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Johns Hopkins University","has_results":false}],"total":44},"guidelines":[],"source":"Drug Landscape verified database"}